Efficacy and Safety of Oral Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analyses
Obesity is a major global health burden with limited long-term pharmacological options. Injectable semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has shown substantial weight loss, particularly in type 2 diabetes mellitus (T2DM). The efficacy of oral semaglutide in non-diabetic populations remains unc...